NIH Revises Rules Governing Inventions Developed Under Bayh-Dole Act

Similar documents
California Consumer Privacy Act: European-Style Privacy With a California Enforcement Twist

Sedona Provides Updated, Practical Guidance for Legal Holds

Status Quo at the PTAB for Now: Supreme Court Makes No Change to IPR; Judicial Review and Claim Construction Standard Remain the Same

The 100-Day Program at the ITC

The Telephone Consumer Protection Act Overview

Depository Financial Institution Liability: Tough Lessons Learned About Fraudulent Electronic Funds Transfers

Adopting AAA Rules to Govern Arbitration Proceedings May - or May Not - Allow U.S. Arbitrators to Decide Gateway Questions of Arbitrability

Defendants Look for Broader Interpretation of Halliburton II

Patent Basics for Emerging Companies. Maria Laccotripe Zacharakis, Ph.D. Thomas Hoover Daniel J. Kelly McCarter & English, LLP

INVENTION DISCLOSURE FORM

Wilmington Update. Delaware Supreme Court and the Court of Chancery Offer Obligation Guidance for Financially Troubled Entities

Patent Rights Retention by the Contractor (Short Form)

HIPAA Privacy Compliance Initiative: Final Rules Impact Employer Health Plans

Financial ServicesAlert

FINAL RULES IMPLEMENTING EIGHTEEN MONTH PUBLICATION OF PATENT APPLICATIONS

USPTO Final Rule Changes for Continuations and Claims. John B. Pegram Ronald C. Lundquist August 30, 2007

INTERPLAY Patent-Related Issues in the Government Contracts Universe

POTENTIAL PATENT APPLICATION QUESTIONNAIRE

CUSTOMER CONTRACT REQUIREMENTS A-160 HUMMINGBIRD CUSTOMER CONTRACT N

Overview of the Patenting Process

Supreme Court s Cyan Decision Means Open Season for Investor Class Actions After IPOs

STANDARD NAVY COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT BETWEEN [NAVY COLLABORATOR] AND [NON-NAVY COLLABORATOR]

HOW IS THE NLRB S NEW ELECTION PROCESS AFFECTING CAMPUS ORGANIZING?

Benefits and Dangers of U.S. Provisional Applications

Compilation date: 24 February Includes amendments up to: Act No. 61, Registered: 27 February 2017

First Inventor to File: Proposed Rules and Proposed Examination Guidelines

BASICS OF PATENTS By Howard Cohn Registered Patent Attorney

M&A REGULATORY DEVELOPMENTS AT FERC 2016 ANNUAL REVIEW. Mark C. Williams J. Daniel Skees Heather L. Feingold December 15, 2016

AUSTRALIA Patents Act 1990 Compilation date: 24 February 2017 Includes amendments up to: Act No. 61, 2016 Registered: 27 February 2017

Patents. What is a Patent? 11/16/2017. The Decision Between Patent and Trade Secret Protection

Section 5 Exceptions to Lack of Novelty of Invention (Patent Act Article 30)

1. The following prime contract special provisions apply to this purchase order:

Changes To Implement the First Inventor To File Provisions of the Leahy-Smith America Invents Act Final Rules

New Patent Application Rules Set to Take Effect November 1, 2007

SEC. 11. FEES FOR PATENT SERVICES.

City State Country Zip. Contact Name Telephone Fax

Priority Claims, Incorporation By Reference, and how to fix errors, big and small. March 9, Jack G. Abid. Orlando, Florida

Louisiana State University System

National Cooperative Research and Production Act of ~ as amended on June 22, 2004 by the ~

Three Types of Patents

MASSACHUSETTS INSTITUTE OF TECHNOLOGY OFFICE OF SPONSORED PROGRAMS RESEARCH AGREEMENT

The Honorable David J. Kappos Under Secretary of Commerce for Intellectual Property Director of the United States Patent and Trademark Office

PENNSYLVANIA BAR ASSOCIATION LEGAL ETHICS AND PROFESSIONAL RESPONSIBILITY COMMITTEE RESOLUTION

Patent and License Overview. Kirsten Leute, Senior Associate Office of Technology Licensing, Stanford University

Changes to Implement the First Inventor to File Provisions of the Leahy-Smith. AGENCY: United States Patent and Trademark Office, Commerce.

United States Court of Appeals for the Federal Circuit

RESEARCH AGREEMENT. Rochester, through the Department in the School of, has valuable experience, and skill, and ability in.

Chapter 36 Mediation and Arbitration 2013 EDITION Declaration of purpose of ORS to

LATVIA Patent Law adopted on 15 February 2007, with the changes of December 15, 2011

RELIBIT LABS MUTUAL NON DISCLOSURE AGREEMENT

This document gives a brief summary of the patent application process. The attached chart shows the most common patent protection routes.

An ANDA Update. June 2004 Bulletin 04-50

Patent Cooperation Treaty

Introduction. 1 These materials are public information and have been prepared solely for educational and entertainment purposes to contribute

5Things You Need to Know

Chapter 36 Mediation and Arbitration 2015 EDITION

PATENT PROSECUTION STRATEGIES IN AN AIA WORLD: SUCCEEDING WITH THE CHANGES

Implications and Considerations for In-House Counsel in the Implementation of AIA First Inventor to File Provisions

COLLABORATIVE RESEARCH AGREEMENT AND ALLOCATION OF RIGHTS IN INTELLECTUAL PROPERTY UNDER AN STTR RESEARCH PROJECT between. and

Secured Services Web Site Administrator Agreement

This document gives a brief summary of the patent application process. The attached chart shows the most common patent protection routes.

COMPANIES AND INTELLECTUAL PROPERTY COMMISSION (CIPC) (SOUTH AFRICA)

America Invents Act of 2011 Part 1: Impact on Litigation Strategy Part 2: Strategic Considerations of the FTF Transition

Litigation Webinar Series. Hatch-Waxman 101. Chad Shear Principal, San Diego

Intellectual Property. EMBL Summer Institute 2010 Dusty Gwinn WVURC

NC General Statutes - Chapter 66 Article 29 1

Patent Law of the Republic of Kazakhstan

Basic Patent Information from the USPTO (Redacted) November 15, 2007

THE ACTS ON AMENDMENTS TO THE PATENT ACT */**/***/****/*****/******/*******

The America Invents Act and its Effect on Universities: It Goes Beyond Just Patents. Carl P. B. Mahler II, JD UNC Charlotte

HUNGARY Patent Act Act XXXIII of 1995 as consolidated on March 01, 2015

Part Two Conditions and Provisions for Filing an Application Article 8

Patent Act, B.E (1979) As Amended until Patent Act (No.3), B.E (1999) Translation

WHAT TO EXPECT WHEN YOU RE EXPECTING A PATENT By R. Devin Ricci 1

LUXEMBOURG Patent Law as amended by the law of May 24, 1998 ENTRY INTO FORCE: June 21, 1998

Exclusions from patentability 15 Inventions contrary to public order or morality not patentable

HONG KONG Patents (General) Rules as amended by L.N. 40 of 2004 ENTRY INTO FORCE: May 7, 2004 Chapter: 514C

COMMERCIAL EVALUATION LICENSE AGREEMENT PURDUE RESEARCH FOUNDATION [ ] PRF Docket No.:

Patent Cooperation Treaty

Accelerated Examination. Presented by Hans Troesch, Principal Fish & Richardson P.C. March 2, 2010

Digital lab notebooks and intellectual property protection

How patents work An introduction for law students

Understanding and Applying the CREATE Act in Collaborations

Change in Procedure Relating to an Application Filing Date

I. Preamble. Patent Policy Page 1 of 13

Sponsored Clinical Research Agreement

(Revised June 25, 2013)

United States v. Biocompatibles, Inc. Criminal Case No.

2001 through 2017 IPLEGALED, Inc. All Rights Reserved

MBHB snippets Alert October 13, 2011

UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF FLORIDA PATENT CASE SCHEDULE. Answer or Other Response to Complaint 5 weeks

(Translated by the Patent Office of the People's Republic of China. In case of discrepancy, the original version in Chinese shall prevail.

NON-STANDARD NAVY COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT BETWEEN THE NAVAL RESEARCH LABORATORY (NRL) AND XYZ CORPORATION (XYZ)

STEVENSON-WYDLER (15 U.S.C. 3710a) COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT (hereinafter CRADA ), No. YY-NNNC], between

Patent Litigation for the Non-Specialist: How it Works and What to Expect

Patent Litigation for the Non-Specialist: How it Works and What to Expect

UNITED KINGDOM Patent Rules 2007 as amended up to and including October 1, 2014

AZERBAIJAN Law on Patent Date of Text (Enacted): July 25, 1997 ENTRY INTO FORCE: August 2, 1997

IxANVL Binary License Agreement

ETHERCAT SLAVE STACK CODE LICENSE

Transcription:

NIH Revises Rules Governing Inventions Developed Under Bayh-Dole Act ALERT March 7, 2019 Hilary S. Cairnie cairnieh@pepperlaw.com N. Nicole Stakleff stakleffn@pepperlaw.com The National Institutes of Health (NIH) recently issued its revised Grant Policy Statement (GPS), which implements significant changes to the Bayh-Dole rules governing inventions developed under NIH-funded grants and cooperative agreements, as well as changes to other GPS requirements. The changes took effect on October 1, 2018. Companies, universities, hospitals and nonprofit entities that receive NIH funding under grants or cooperative agreements should pay particular attention to the ownership and licensing rights associated with intellectual property especially patentable inventions developed under these agreements. The revised GPS imposes new requirements and modifies certain duties and reporting timelines for disclosing inventions, electing title to THIS PUBLICATION MAY CONTAIN ATTORNEY ADVERTISING The material in this publication was created as of the date set forth above and is based on laws, court decisions, administrative rulings and congressional materials that existed at that time, and should not be construed as legal advice or legal opinions on specific facts. The information in this publication is not intended to create, and the transmission and receipt of it does not constitute, a lawyer-client relationship. Please send address corrections to phinfo@pepperlaw.com. 2019 Pepper Hamilton LLP. All Rights Reserved.

inventions, and filing patent applications. Failure to satisfy each of these requirements could result in forfeiture of the funding recipient s ownership and licensing rights. Now is a good time for NIH funding recipients to examine the changed requirements, assess the impact that those changes may have on their operations, and revise their compliance policies and procedures, as necessary. For grants and cooperative agreements awarded before October 1, 2018, the earlier version of the NIH GPS still governs those agreements. However, new and continuation awards made on or after that date will be subject to revised GPS. Below we summarize some of the most important provisions and changes in the revised GPS. Disclosure of Subject Invention Two Months. A recipient of NIH funding is required to formally disclose each subject invention developed under the grant or cooperative agreement within two months of the inventor s disclosure of the invention to the recipient official responsible for patent matters. This reporting requirement remains unchanged as to timing. NIH now requires that all subject invention disclosures must be made using the government web portal, iedison. Paper disclosures are no longer permitted. The funding recipient should retain electronic copies of all invention disclosures. Initial Patent Application. The initial patent application has been redefined to mean the first provisional or nonprovisional patent application filed in the United States or the first international application filed under the Patent Cooperation Treaty, which designates the United States or the first application for a Plant Variety Protection certificate. 37 CFR 401.2(n). Ten Months to File Nonprovisional Application. If the initial patent application for a subject invention is a provisional application, NIH has shortened the period of time for filing a nonprovisional application from 12 months to 10 months after filing the provisional application. Even though the patent statute allows up to one year to file a nonprovisional application, for NIH purposes, the agency has truncated that statutory period. Accordingly, a recipient s patent counsel must be made aware that a provisional application is directed to an invention that was funded in whole or in part by an NIH grant or cooperative agreement and is therefore subject to the shortened time period for filing the nonprovisional application.

Election to Retain Title to Subject Inventions Two Years or Less. The NIH funding recipient still has two years following timely disclosure of a subject invention in which to file the required notice of its election to retain title to the subject invention. This election period may be shortened under several circumstances, including if the subject invention has been used publicly, sold or offered for sale in commerce, disclosed in a publication or publicly displayed, or any other event that would trigger the one-year statutory period wherein valid patent protection can still be obtained. In that case, the period for filing the election notice may be shortened by the agency to a date that is not more than 60 days before the end of the statutory period. Again, recipients should fully inform patent counsel and compliance personnel of all activities that could shorten the period for filing the election notice with the agency and timely filing the initial patent application. Funding Attribution in U.S. Patent Applications. When claiming a subject invention in a patent application, the recipient is required to include a funding attribution statement in each application that informs the world that U.S. government funding supported development of the claimed invention. The required attribution is: This invention was made with government support under [identify contract no.] awarded by [identify agency]. The government has certain rights in the invention. It is important that the recipient inform patent counsel that the claimed subject invention was funded, in whole or in part, with government support. Notification of Initial Patent Application. Within one year after filing the notice of title election, or before expiration of the statutory period for obtaining valid patent protection in the United States, the recipient must inform NIH of the date of filing the initial patent application, the application number and the title of the patent application. This information must also be provided for all subsequently filed patent applications. The deadline for submitting this information may be extended by NIH upon request. Extensions of Time for Disclosure of Subject Invention, Election of Title Notification, and Notification of Initial Patent Application. So long as the applicable period of time has not lapsed, the recipient may request in writing an extension of time for disclosure of a subject invention, a notice of title election, or a notification of an initial patent application. This is important. Unless a request for extension is received before the applicable filing period has expired (two months for subject invention disclosure, two years or less for title election notification, and one year or less for notification of an initial patent application), NIH will not grant an extension. A late request for an extension will not be considered.

Forfeiture of Right to Own Subject Invention. It is a common misperception among recipients that, at the time of award, they will be the legal owner of any subject inventions. That is simply wrong. Under the NIH GPS, recipients have a right to retain ownership but that right can only be perfected if the recipient timely complies with the requirements to disclose the subject invention to the agency, timely files its notice of election to retain title to the subject invention, and timely files a patent application. Overlooking any one of these requirements results in forfeiture of the recipient s ownership rights, and NIH then has the right to retain ownership of the subject invention. Government Election to Own or Forgo Ownership of Subject Invention Forfeited by Contractor. Once NIH first learns of the subject invention and the recipient s failure to timely disclose the subject invention or timely file a notice of election to retain title, NIH may, at any time thereafter, elect to retain title or forgo ownership of the subject invention. Previously, NIH had to act on its rights within 60 days after which, if it did not inform the recipient of its decision, title to the subject invention would revert back to the recipient. That provision has been deleted in the revised GPS. If the recipient has failed to comply, NIH now has an indefinite period of time in which to decide whether it wants to own the subject invention or not. If the subject invention happens to be a blockbuster new therapy, vaccine or device, the forfeiture of the recipient s ownership rights could prove to be quite costly to the recipient. And, if that is not bad enough, the failure to timely disclose a subject invention or elect to retain title will also result in the loss of any right to receive a license to the invention if the government decides to retain title to that invention. The recipient could find itself without any legal remedy and, more importantly, no legal entitlement to participate in the marketplace. iedison Is Mandatory. This government-wide portal is now the only mechanism permitted by NIH for filing the disclosure of a subject invention, notice of election to retain title, close-out reports and all other compliance documents. As of October 1, 2018, recipients must use the portal for all filings for all grants and cooperative agreements awarded or continued on or after that date. Training Requirement. Recognizing that NIH s compliance requirements associated with inventions and patents are complicated, NIH requires recipients to conduct appropriate training to mitigate the risk that their employees may unintentionally overlook one or more reporting requirements and, in so doing, compromise the recipient s ownership and licensing rights in subject inventions. Recipients should actively engage and educate to ensure an adequate understanding of, and compliance with, these requirements.

There are many other changes embodied in the revised GPS, and recipients should undertake appropriate due diligence to review the new requirements; assess the impact the new rules will have on their rights, remedies, duties and obligations under NIH grants and cooperative agreements; and modify, as necessary, their policies and procedures to insure that they are fully compliant with the updated GPS. If you have any questions on your possible compliance burden, please contact Hilary S. Cairnie, N. Nicole Stakleff, or a member of Pepper Hamilton s Government Contracts Practice Group or Intellectual Property Department. Berwyn Boston Detroit Harrisburg Los Angeles New York Orange County Philadelphia Pittsburgh Princeton Rochester Silicon Valley Washington Wilmington pepper.law